Correction: Yagolovich et al. DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma. Int. J. Mol. Sci. 2022, 23, 12687
Anne V. Yagolovich, Alina A. Isakova, Artem A. Artykov, Yekaterina V. Vorontsova, Diana V. Mazur, Nadezhda V. Antipova, Marat S. Pavlyukov, Mikhail I. Shakhparonov, Anastasia M. Gileva, Elena A. Markvicheva, Ekaterina A. Plotnikova, Andrey A. Pankratov, Mikhail P. Kirpichnikov
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Research and Treatments · Ubiquitin and proteasome pathways · ATP Synthase and ATPases Research
In the original publication [1], there was a mistake in Figure 4D as published. Due to the similar lack of cytotoxic effects, the control 0.000 nM/DR5-B image was accidentally replaced with a part of the 0.005 nM/DR5-B image. However, the error does not have a critical impact on the results, since the lack of cytotoxicity of 0.005 nM DR5-B is also confirmed by the viability data (see Figure 4B). The authors sincerely apologize for the confusion. The corrected Figure 4 appears below.
To specifically clarify the conflicts of interest in the original publication [1], the corrected Conflicts of Interest appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Yagolovich A.V. Isakova A.A. Artykov A.A. Vorontsova Y.V. Mazur D.V. Antipova N.V. Pavlyukov M.S. Shakhparonov M.I. Gileva A.M. Markvicheva E.A. DR 5-Selective TRAIL Variant DR 5-B Functionalized with Tumor-Penetrating i RGD Peptide for Enhanced Antitumor Activity against Glioblastoma Int. J. Mol. Sci.2022231268710.3390/ijms 23201268710.3390/ijms 23201268736293545 PMC 9604365 · doi ↗ · pubmed ↗